February 1, 2025

The New UAE Pharmaceutical Law | Mike Eybers and Christina Sochacki

With the new UAE pharmaceutical law coming into effect in January 2025, Christina Sochacki, Partner, Head of Healthcare and Life Sciences – Saudi Arabia, sits down with Michael Eybers, Associate, to discuss the major shifts that are underway in the regulatory landscape.

This law is set to streamline approvals, modernize distribution models, and open new opportunities for investment in the UAE’s thriving healthcare and life sciences sector.

We will be looking at new pathways for expediting drug registrations, especially for orphan drugs and public health emergencies, some Regulatory Transition, like Oversight shifts from the Ministry of Health to the newly formed Emirates Drug Establishment (EDE), and Distribution Changes such as updates to importer and distributor requirements which could reshape the market dynamics.

With executive regulations on the horizon, pharmaceutical companies and investors should stay ahead of these changes.

Watch the full video for expert insights!

#ArabHealth2025 #UAEpharmaceuticallaw #TeamTamimi